Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023
Emerging Infectious Diseases · 2026-02 · 32 (2)
DOI: 10.3201/eid3202.251043 ↗Kurz gefasst
Leserbrief in der Zeitschrift Emerging Infectious Diseases, 2026-02. Verfasst von Jessica E Laury und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antifungal Agents, Candida auris, Drug Resistance, Fungal, Candidiasis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Laury, J. E., Forsberg, K., Berkow, E. L., Jones, S., Sexton, D. J., Sievert, D. M., Lockhart, S. R., Gold, J. A. W., & Lyman, M. (2026). Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023. Emerging Infectious Diseases, 32(2). https://doi.org/10.3201/eid3202.251043
Vancouver
Laury JE, Forsberg K, Berkow EL, Jones S, Sexton DJ, Sievert DM, et al. Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023. Emerging Infectious Diseases. 2026;32(2). doi:10.3201/eid3202.251043
BibTeX
@article{Laury2026,
author = {Laury, Jessica E and Forsberg, Kaitlin and Berkow, Elizabeth L and Jones, Sophie and Sexton, D Joseph and Sievert, Dawn M and Lockhart, Shawn R and Gold, Jeremy A W and Lyman, Meghan},
title = {Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023},
journal = {Emerging Infectious Diseases},
year = {2026},
volume = {32},
number = {2},
doi = {10.3201/eid3202.251043}
}
EUVIMED